Enasidenib
id:
enasidenib-184-4766454
title:
Enasidenib
text:
Enasidenib, sold under the brand name Idhifa, is an anti-cancer medication used to treat relapsed or refractory acute myeloid leukemia. It is an inhibitor of isocitrate dehydrogenase 2 (IDH2). Common side effects of enasidenib include nausea, vomiting, diarrhea, increased levels of bilirubin, and decreased appetite. Women who are pregnant or breastfeeding should not take enasidenib because it may cause harm to a developing fetus or a newborn baby. Enasidenib was approved for medical use in the U
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Enasidenib
date created:
2017-01-31T19:00:22Z
date modified:
2024-09-07T05:33:08Z
main entity:
{"identifier":"Q27077182","url":"https://www.wikidata.org/entity/Q27077182"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/47/Enasidenib.svg","width":512,"height":337}
fields total:
13
integrity:
16